Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
Date:7/29/2009

ties (37.6) (29.4) ----- ----- Cash Flows from Financing Activities: Payments on term loan, current debt and other long-term liabilities (1.6) (95.0) Proceeds from issuance of short-term debt - 17.0 Proceeds from stock plans 10.1 2.2 Repurchase of common stock (2.2) (0.1) ---- ---- Net cash provided by (used in) financing activities 6.3 (75.9) ----- ----- Net increase in cash and cash equivalents 129.9 60.9 Cash and cash equivalents at beginning of period 507.6 204.6 ----- ----- Cash and cash equivalents at end of period $637.5 $265.5 ====== ======

The following table presents a reconciliation of reported net income and diluted earnings per share to adjusted net income and diluted earnings per share for the three and six months ended June 30, 2009 and 2008:

                                                              Table 4
                               Watson Pharmaceuticals, Inc.
                                  Reconciliation Table
                   (Unaudited; in millions except per share amounts)

                                  Three Months Ended       Six Months Ended
                                       June 30,                June 30,
                                   2009        2008        2009       2008
                                   ----        ----        ----       ----

    GAAP to adjusted ne
'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
2. Watson CFO Mark W. Durand to Take Leave of Absence
3. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
4. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
5. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
6. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
7. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. Watson to Acquire Arrow Group
10. Watson Files FDA Application for Generic Mucinex(R) D
11. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... (PRWEB) March 30, 2015 This ... has been designed to provide medical professionals with ... restrictions. Anatomy and physiology of fascia and its ... throughout the course. This PT CME course ... assessment and palpation skills to identify and treat ...
(Date:3/30/2015)... Mirada, CA (PRWEB) March 30, 2015 ... drug screens for employers and companies throughout ... job applicants are using drugs. It can identify ... illicit drugs. Employers, sports teams, D.O.T. applicants, and students ... , The features of the drug screen program ...
(Date:3/30/2015)... Join local United Methodists as they Rethink Church ... to provide healthcare for the 512 students at Raise ... on Saturday, April 18, at 9 a.m. at Edwin ... Road in Nashville. , Raise the Roof Academy in ... medical care. The nearest clinic is a three-hour walk. ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Foundations Recovery ... to announce the start of its 41st national conference ... Jane McGonigal, and former Congressman Patrick J. Kennedy as ... Conference being held in San Diego, CA, March 30 ... The national conference brings together leading experts specializing in ...
(Date:3/30/2015)... Sacramento, Calif. (PRWEB) March 30, 2015 ... and CDA, the CDA Cares free, two-day dental clinic ... to 2,080 people March 27-28. , In addition ... to Californians who experience barriers to care, CDA Cares ... good oral health and the need for an adequately ...
Breaking Medicine News(10 mins):Health News:North American Seminars received New Jersey and California approval for Myofascial Release - From Surface to the Depths, a PT and OT Continuing Education Course. 2Health News:Drug Screens Now at Healthpointe 2Health News:Drug Screens Now at Healthpointe 3Health News:Hike2Heal and Rethink Church Raise Funds To Provide Healthcare for Ugandan Children with 3rd Annual Raise the Roof 5K on April 18 2Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:CDA Cares Sacramento Dental Clinic Provides $2 Million in Care 2
... through an animal study that Aspartame can cause lymphoma, ... five 20-ounce bottles of diet soda sweetened with aspartame ... ,The study would be published in March issue ... journal., ,The method and sample adopted were feeding ...
... short breaks can go a long way in making ... study conducted by Massachusetts Institute researchers. // ... Massachusetts Institute of Technology in Cambridge, found that rats' ... pause briefly to rest., ,They suggest that eliminating ...
... cell research in the state with the approval of 61% ... have impeded the initiative. // ,The officials now ... will be initiated. Zach Hall, president of the California Institute ... would commence the project as soon as possible. ...
... Howard has allocated $1.1 billion in health reforms. But his ... ,Mr. Howard said that there was more mental illness previously ... thing is to move on with one’s life. ... ill-informed. ,Though he said that in reality mental ...
... Honolulu: The Hawaii State Hospital has gone down the ranks ... crowding, a status report has revealed//. The status report quotes, ... to meet the June 30th deadline, required to bring the ... had received a one-year extended timeframe till June 30 to ...
... the help of prisoners from Beur jail in Patna to ... near the jail and begged for money to fulfill the ... was kidnapped in Phulwarisharief while he was on his way ... to use their contacts outside the jail to help trace ...
Cached Medicine News:Health News:Task Learning Made Simple By Taking Short Breaks 2Health News:Momentum of Stem cell research impeded by legal challenges 2
(Date:3/30/2015)... 31 mars 2015  Une équipe de scientifiques chinois ... d,un récepteur de surface cellulaire qui joue ... thromboses. Contre toute attente, cette recherche a ... structurelles qui remettent en cause les idées ... récepteurs couplés aux protéines G (RCPG) et ...
(Date:3/30/2015)... Calif., March 30, 2015 Shareholder rights attorneys ... proposed acquisition of Hyperion Therapeutics, Inc. (NASDAQ: HPTX ... On March 30, 2015, the two companies announced the ... Horizon will acquire Hyperion.  Under the terms of the ... each share of Hyperion common stock. ...
(Date:3/30/2015)... , March 30, 2015 TapImmune ... its participation at the Fifth Annual "Cancer Immunotherapy: A Long-Awaited ... in New York City on ... Dr. Glynn Wilson , Chairman & CEO of ... to the Company.  Regrettably, due to parallel meeting sessions running behind ...
Breaking Medicine Technology:De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 2De nouvelles structures moléculaires remettent en cause les idées conventionnelles concernant l'action des médicaments sur les récepteurs 3Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 2Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 3Presentation at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" 2Presentation at the Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" 3
... Percutaneous Administration (CUPID) Data Highlight Safety Profile and ... 26 Celladon Corporation today announced that results ... advanced heart failure, including Phase 1/2 data of ... Zsebo, PhD, President and CEO, Celladon Corporation and ...
... 26 Senesco Technologies, Inc. ("Senesco" or the "Company") ... mouse influenza survival studies that were conducted in Dr. William Scheld,s ... Mice treated with an siRNA against Senesco,s Factor 5A gene ... rate for mice that received no treatment or a control siRNA.A ...
Cached Medicine Technology:Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy 2Senesco Announces H1N1 Influenza Survival Test Results in Mice 2Senesco Announces H1N1 Influenza Survival Test Results in Mice 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: